E-LIB Suche - Ergebnisse für: Miguel Silva, Luis

1

Serum potassium levels provide prognostic information in sy..:

Toledo, Camila Cristiane ; Vellosa Schwartzmann, Pedro ; Miguel Silva, Luis...
ESC Heart Failure. 8 (2021) 3 - p. 2133-2143 , 2021

Link: https://doi.org/10.1002/..

2

Cost-effectiveness of semaglutide 2.4 mg in chronic weight ..:

Silva Miguel, Luís ; Soares, Mariana ; Olivieri, Anamaria...
Diabetology & Metabolic Syndrome. 16 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Economic evaluations of medical devices in paediatrics: a s..:

Mascarenhas, Edgar ; Miguel, Luís Silva ; Oliveira, Mónica D.
Cost Effectiveness and Resource Allocation. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

OR46 THE IMPACT ON PRODUCTIVITY COSTS OF REDUCING UNEMPLOYM..:

Matos, Leonor ; Borges, Margarida ; Oliveira, Ana Teresa...
The Breast. 71 (2023) - p. S28 , 2023

Link: https://doi.org/10.1016/..

5

Anticoagulação Oral e Incidência de Acidente Vascular Cereb..:

Ascenção, Raquel ; Gil, Madalena ; Lourenço, Francisco...
Acta Médica Portuguesa. 36 (2023) 7-8 - p. 458-466 , 2023

Link: https://doi.org/10.20344..

6

The cost-saving switch from inhaled corticosteroid-containi..:

Souliotis, Kyriakos ; Silva Miguel, Luís ; Hillas, Georgios...
Therapeutic Advances in Respiratory Disease. 14 (2020) - p. 175346662092680 , 2020

Link: https://doi.org/10.1177/..

7

Cost-effectiveness of cladribine tablets versus fingolimod ..:

Pinheiro, Bernardete ; Guerreiro, Rita ; Costa, João.
Journal of Medical Economics. 23 (2020) 5 - p. 484-491 , 2020

Link: https://doi.org/10.1080/..

8

Cost Effectiveness of Pembrolizumab for Advanced Melanoma T..:

Miguel, Luis Silva ; Lopes, Francisca Vargas ; Pinheiro, Bernardete...
Value in Health. 20 (2017) 8 - p. 1065-1073 , 2017

Link: https://doi.org/10.1016/..

9

Cost‐Effectiveness Analysis of Obinutuzumab for Previously ..:

Paquete, Ana Teresa ; Miguel, Luís Silva ; Becker, Ursula..
Applied Health Economics and Health Policy. 15 (2017) 4 - p. 501-512 , 2017

Link: https://doi.org/10.1007/..

10

Clinical and economic consequences of using dabigatran or r..:

Silva Miguel, Luís ; Ferreira, Jorge
Revista Portuguesa de Cardiologia (English Edition). 35 (2016) 3 - p. 141-148 , 2016

Link: https://doi.org/10.1016/..

11

Consequências clínicas e económicas da utilização de dabiga..:

Silva Miguel, Luís ; Ferreira, Jorge
Revista Portuguesa de Cardiologia. 35 (2016) 3 - p. 141-148 , 2016

Link: https://doi.org/10.1016/..

12

Comment on "Cost-effectiveness of rivaroxaban for stroke pr..:

Silva Miguel, Luís
Revista Portuguesa de Cardiologia (English Edition). 34 (2015) 11 - p. 705-706 , 2015

Link: https://doi.org/10.1016/..

13

Comentário a estudo de custo‐efetividade de rivaroxabano pa..:

Silva Miguel, Luís
Revista Portuguesa de Cardiologia. 34 (2015) 11 - p. 705-706 , 2015

Link: https://doi.org/10.1016/..

14

A cost-utility analysis of pregabalin versus venlafaxine XR..:

Silva Miguel, Luís ; Silva Miguel, Nuno ; Inês, Mónica
Cost Effectiveness and Resource Allocation. 11 (2013) 1 - p. 8 , 2013

Link: https://doi.org/10.1186/..

15

Economic evaluation of dabigatran for stroke prevention in ..:

Silva Miguel, Luís ; Rocha, Evangelista ; Ferreira, Jorge
Revista Portuguesa de Cardiologia (English Edition). 32 (2013) 7-8 - p. 557-565 , 2013

Link: https://doi.org/10.1016/..